The effects of caffeine on the brain: A review

Journal of Neurotherapy

Volumn 7, Issue 2, 2003, Pages 79-89

  Hammond, D Corydon ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Caffeine; Caffeine withdrawal; EEG; QEEG

Indexed keywords

CAFFEINE;

ADDICTION; ANXIETY; BETA RHYTHM; BRAIN FUNCTION; CLINICAL TRIAL; DELTA RHYTHM; ELECTROENCEPHALOGRAPHY; FEEDBACK SYSTEM; HUMAN; INSOMNIA; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RELIABILITY; REVIEW; SLOW BRAIN WAVE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; THETA RHYTHM; WITHDRAWAL SYNDROME;

EID: 0142094201     PISSN: 10874208     EISSN: None     Source Type: Journal    
DOI: 10.1300/J184v07n02_07     Document Type: Review

References (57)

1. Axelrod, J., & Reisenthal, J. (1953). The fate of caffeine in man and a method for its estimation in biological material. Journal of Pharmacology & Experimental Therapeutics, 107, 519-523.
2. Boulenger, J. P., & Uhde, T. W. (1982). Caffeine consumption and anxiety: Preliminary results of a survey comparing patients with anxiety disorders and normal controls. Psychopharmacology Bulletin, 18, 53-57.
3. Boulenger, J. P., Uhde, T. W., Wolff, E. A., & Post, R. M. (1984). Increased sensitivity to caffeine in patients with panic disorder: Preliminary evidence. Archives of General Psychiatry, 41, 1067-1071.
4. Bruce, M., Scott, N., Lader, M., & Marks, V. (1986). The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects. British Journal of Clinical Pharmacology, 22, 81-87.
5. Bruce, M., Scott, N., Shine, P., & Lader, L. (1992). Anxiogenic effects of caffeine in patients with anxiety disorders. Archives of General Psychiatry, 49, 867-869.
6. Chait, L. D., & Griffiths, R. R. (1983). Effects of caffeine on cigarette smoking and subjective response. Clinical Pharmacology & Therapeutics, 34, 612-622.
7. Charney, D. S., Heninger, G. R., & Jatlow, P. I. (1985). Increased anxiogenic effects of caffeine in panic disorders. Archives of General Psychiatry, 42, 233-243.
8. Christensen, L., Bourgeois, A., & Cockroft, R. (1993). Electroencephalographic concomitants of a caffeine-induced panic reaction. Journal of Nervous & Mental Disease, 181 (5), 327-330.
9. Dimpfel, W., Schober, F., & Spuler, M. (1993). The influence of caffeine on human EEG under resting conditions and during mental loads. Journal of Clinical Investigation, 71, 197-207.
10. Etevenon, P., Peron-Magnan, P., Boulenger, J. P., Tortrat, D., Guillou, S., Toussaint, M., et al. (1986). EEG cartography profile of caffeine in normals. Clinical Neuropharmacology, 9 (Supplement 4), 538-540.
11. Etevenon, P., Peron-Magnan, P., Guillou, S., Toussaint, M., Guegen, B., Deniker, P., et al. (1988). A pharmacological model of cerebral local activation: EEG cartography of caffeine effects in normals. Chapter in G. Pfurtscheller & F. H. Lopes da Silva (Eds.), Functional brain imaging. Bern: Huber.
12. Evans, S. M., & Griffiths, R. R. (1991). Low dose caffeine physical dependence in normal subjects: Dose-related effects. Chapter in L. Harris (Ed.), Problems of drug dependence 1990: Proceedings of the 52nd Annual Scientific Meeting, Committee on Problems of Drug Dependence, Inc. NIDA Research Monograph 105 (pp. 446-447). Washington, DC: U.S. Government Printing Office.
13. Fink, M., Taylor, M., & Volavka, J. (1969). Anxiety precipitated by lactate. New England Journal of Medicine, 281, 1429.
14. Gilbert, D. G., Dibb, W. D., Plath, L. C., & Hiyane, S. G. (2000). Effects of nicotine and caffeine, separately and in combination, on EEG topography, mood, heart rate, cortisol, and vigilance. Psychophysiology, 37, 583-595.
15. Goldstein, L., Murphree, H. B., & Pfeiffer, C. C. (1963). Quantitative electroencephalography in man as a measure of CNS stimulation. Annals of the New York Academy of Sciences, 107, 1045-1056.
16. Griffiths, R. R., Evans, S. M., Heishman, S. J., Preston, K. L., Sannerud, C. A., Wolf, B., et al. (1990). Low-dose caffeine physical dependence in humans. Journal of Pharmacology & Experimental Therapeutics, 225, 1123-1132.
17. Griffiths, R. R., & Mumford, G. K. (1995). Caffeine - a drug of abuse? Chapter in F. E. Bloom & D. J. Kupfer (Eds.). Psychopharmacology: The fourth generation in progress (pp. 1699-1713). New York: Raven Press.
18. Griffiths, R. R., & Woodson, P. P. (1988). Caffeine physical dependence: A review of human and laboratory animal studies. Psychopharmacology, 94, 437-451.
19. Hasenfratz, M., & Battig, K. (1994). Acute dose-effect relationships of caffeine and mental performance, EEG, cardiovascular and subjective parameters. Psychopharmacology, 114, 281-287.
20. Jones, H. E., Griffiths, R. R., Herning, R. I., & Cadet, J. L. (2000). Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity. Psychopharmacology, 147, 371-377.
21. Karacan, I., Thornby, J. I., Anch, A. M., Booth, G. H., Williams, R. L., & Salis, P. J. (1976). Dose-related sleep disturbances induced by coffee and caffeine. Clinical Pharmacology & Therapy, 20, 682-689.
22. Kenemans, J. L., & Lorist, M. (1995). Caffeine and selective visual processing. Pharmacology & Biochemistry of Behavior, 52, 461-471.
23. Knott, V., Chaudry, R., & LaPierre, Y. D. (1981). Panic induced by sodium lactate: Electrophysiological correlates. Progress in Neuropsychopharmacology & Biological Psychiatry, 5, 511-514.
24. Landolt, H. P., Dijk, D.-J., Gans, S. E., & Borbely, A. A. (1995). Caffeine reduces low-frequency delta activity in the human sleep EEG. Neuropsychopharmacology, 12 (3), 229-238.
25. Landolt, H. P., Werth, E., Borbely, A. A., & Dijk, D. J. (1995). Caffeine intake (200 mg) in the morning affects human sleep and EEG power spectra at night. Brain Research, 675, 67-74.
26. LaPierre, Y. D., Knott, V., & Gray, R. (1984). Psychophysiological correlates of sodium lactate. Psychopharmacology Bulletin, 20, 50-57.
27. Lee, M. A., Cameron, O. G., & Greden, J. F. (1985). Anxiety and caffeine consumption in people with anxiety disorders. Psychiatry Research, 15, 211-217.
28. Lee, M. A., Flegel, P., Greden, J. F., & Cameron, O. G. (1988). Anxiogenic effects of caffeine on panic and depressed patients. American Journal of Psychiatry, 145, 632-635.
29. Lesser, I. M., Poland, R. E., Holcomb, C., & Rose, D. E. (1985). Electroencephalographic study of nighttime panic attacks. Journal of Nervous & Mental Disease, 173, 744-746.
30. Lorist, M. M., Snel, J., & Kok, A. (1994a). Influence of caffeine on information processing stages in well rested and fatigued individuals. Psychopharmacology, 113, 411-421.
31. Lorist, M. M., Snel, J., & Kok, A. (1994b). Influence of caffeine on selective attention in well-rested and fatigued subjects. Psychophysiology, 31, 525-534.
32. Lorist, M. M., Snel, J., Mulder, G., & Kok, A. (1995). Aging, caffeine, and information processing: An event-related potential analysis. Electroencephalography & Clinical Neurophysiology, 96, 453-467.
33. Matthew, R. J., & Wilson, W. H. (1985). Caffeine consumption, withdrawal and cerebral blood flow. Headache, 25, 305-309.
34. Matthew, R. J., Barr, D. L., & Weinman, M. L. (1983). Caffeine and cerebral blood flow. British Journal of Psychiatry, 143, 604-608.
35. Mellman, T. A., & Uhde, T. W. (1990). Sleep in panic and generalized anxiety disorders. Chapter in J. C. Ballinger (Ed.), Neurobiology of panic disorder. New York: Wiley-Liss.
36. Mikalsen, A., Bertelsen, B., & Flaten, M. A. (2001). Effects of caffeine, caffeine-associated stimuli, and caffeine-related information on physiological and psychological arousal. Psychopharmacology, 157, 373-380.
37. Nehlig, A., Daval, J. L., & Debry, G. (1992). Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic, and psychostimulant effects. Brain Research & Brain Research Review, 17, 139-169.
38. Nehlig, A., Pereira De Vasconcelos, A., Dumont, I., & Boyet, S. (1990). Effects of caffeine, L-phenylisopropyladenosine and their combination on local cerebral blood flow in the rat. European Journal of Pharmacology, 179, 271-280.
39. Newman, F., Stein, M. B., Trettau, J. R., Coppola, R., & Uhde, T. W. (1992). Quantitative electroencephalographic effects of caffeine in panic disorder. Psychiatry Research: Neuroimaging, 45, 105-113.
40. Nicholson, A. N., & Stone, B. M. (1980). Heterocyclic amphetamine derivatives and caffeine on sleep in man. British Journal of Clinical Pharmacology, 9, 195-203.
41. Patrick, G., Reeves, R. R., & Struve, F. A. (1996). Does caffeine cessation increase firing rates of diffuse paroxysmal slowing dysrhythmia? A serendipitous observation. Clinical Electroencephalography, 27 (2), 76-83.
42. Pollock, V. E., Teasdale, T., Stern, J., & Volavka, J. (1981). Effects of caffeine on resting EEG and response to sine wave modulated light. Electroencephalography & Clinical Neurophysiology, 51, 470-476.
43. Prichard, W. S., Robinson, J. H., DeBethizy, J. D., Davis, R. A., & Stiles, M. F. (1995). Caffeine and smoking: Subjective performance and psychophysiological effects. Psychophysiology, 32, 19-27.
44. Reeves, R. R., Struve, F. A., Patrick, G., & Bullen, J. A. (1995). Topographic quantitative EEG measures of alpha and theta power changes during caffeine withdrawal: Preliminary findings from normal subjects. Clinical Electroencephalography, 26, 154-162.
45. Reeves, R. R., Struve, F. A., & Patrick, G. (2002). Topographic quantitative EEG response to acute caffeine withdrawal: A comprehensive analysis of multiple quantitative variables. Clinical Electroencephalography, 33 (4), 178-188.
46. Rowland, M., & Tozer, T. N. (1980). Clinical pharmacokinetics. Philadelphia: Lea & Febiger.
47. Ruijter, J., Lorist, M. M., & Snel, J. (1999). The influence of different doses of caffeine on visual task performance. Psychophysiology, 13, 37-48.
48. Ruijter, J., Lorist, M. M., Snel, J., & De Ruiter, M. B. (2000). The influence of caffeine on sustained attention: An ERP study. Pharmacology Biochemistry & Behavior, 66 (1), 29-37.
49. Saletu, B., Anderer, P., Kinsperger, K., & Grunberger, J. (1987). Topographic brain mapping of EEG in neuropsychopharmacology. II. Clinical applications (pharmaco EEG imagining). Methods & Findings in Experimental Clinical Pharmacology, 9, 385-408.
50. Saletu, B., Barbanoj, M. J., Anderer, P., Sieghart, W., & Grunberger, J. (1993). Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: Blood levels, EEG mapping and safety evaluation. Methods & Findings in Experimental Clinical Pharmacology, 15, 291-312.
51. Siepmann, M., & Kirch, W. (2002). Effects of caffeine on topographic quantitative EEG. Neuropsychobiology, 45 (3), 161-166.
52. Silverman, K., Evans, S. M., Strain, E. C., & Griffiths, R. R. (1992). Withdrawal syndrome after the double-blind cessation of caffeine consumption. New England Journal of Medicine, 327, 1109-1114.
53. Strain, E. C., Mumford, G. K., Silverman, K., & Griffiths, R. R. (1994). Caffeine dependence syndrome: Evidence from case histories and experimental evaluations. Journal of the American Medical Association, 272, 1043-1066.
54. Uhde, T. W. (1990). Caffeine provocation of panic: A focus on biological mechanisms. Chapter in J. C. Ballinger (Ed.), Neurobiology of panic disorder. New York: Wiley-Liss.
55. Uhde, T. W., Boulenger, J. P., Vittone, B., Siever, L., & Post, R. M. (1985). Human anxiety and noradrenergic function: Preliminary studies with caffeine, clonidine, and yohimbine. Chapter in P. Pichot, P. Berner, R. Wolf, & K. Thau (Eds.), Biological psychiatry, higher nervous activity, Vol. 2. Proceedings of the Seventh World Congress of Psychiatry. New York: Plenum.
56. Victor, B. S., Lubetsky, M., & Greden, J. F. (1981). Somatic manifestations of caffeinism. Journal of Clinical Psychiatry, 42, 185-188.
57. Watters, P. A., Martin, F., & Schreter, Z. (1998). Quadratic dose-response relationship between caffeine (1,3,7-trimethylxanthine) and EEG correlation dimension. Psychopharmacology, 136, 264-271.